Datum & Uhrzeit
Partnering to advance therapies
The Cell & Gene Exchange brings together leaders from patient advocacy groups, industry, academia and government to network, exchange ideas and explore partnership opportunities. This partnering conference will facilitate conversations among patient groups and key stakeholders to advancing potentially curative therapies for life-threatening diseases.
EBD Group and Alliance for Regenerative Medicine have partnered to launch this inaugural event with the goal of facilitating conversations among patient groups and key stakeholders to advancing potentially curative therapies for life-threatening diseases. Attendees can use partneringONE®, a sophisticated online platform to discover potential partners then request and schedule onsite meetings.
The program will highlight the valuable partnering roles of the various stakeholders, showcasing innovative technologies. The conference will also create a platform for researchers to meet with policymakers to gain a better understanding of the commercial opportunities as well as the regulatory and reimbursement landscape.
For more information and online registration please visit our conference website at https://ebdgroup.knect365.com/cellgene-exchange/?utm_source=Multiplier&utm_medium=web&utm_term=BioSaxony&utm_campaign=CGX17.
EBD Group, Inc. and Alliance for Regenerative Medicine (ARM)
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
Alliance for Regenerative Medicine (ARM) is an international multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine worldwide. www.alliancerm.org